ozone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, Z; Peng, Y; Shi, H; Song, L; Xu, J; Xu, T; Zhang, H; Zheng, D | 1 |
1 other study(ies) available for ozone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Microwaves; Ozone; Programmed Cell Death 1 Receptor; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2022 |